Skip to content

Clinical trials

Lymphoma, T-Cell, Cutaneous trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Cutaneous Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20074
20122
20131
20151
20181
20191
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Terminated2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.3
Peter MacCallum Cancer Centre, Australia2
BioCryst Pharmaceuticals1
Celgene1
Children's Oncology Group1
Incyte Corporation1
Karyopharm Therapeutics Inc1
Kyowa Kirin, Inc.1
Millennium Pharmaceuticals, Inc.1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Cutaneous18
Mycosis Fungoides9
Sezary Syndrome7
Lymphoma, Non-Hodgkin6
Lymphoma5
Lymphoma, T-Cell, Peripheral4
Hodgkin Disease3
Lymphoma, B-Cell, Marginal Zone3
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.